Chronic renal failure - a vasculopathic state

Article Abstract:

Chronic kidney disease appears to increase the risk of coronary artery disease independently of other risk factors. Cardiovascular disease accounts for half of all deaths among patients with kidney disease who are on dialysis or have received a kidney transplant. Most cases of end-stage kidney disease are caused by chronic hypertension or diabetes. These conditions can be successfully controlled by antihypertensive drugs and good blood glucose control. Patients with kidney diseases should be carefully examined for signs of coronary artery disease.

Analysis, Cardiovascular diseases, Patient outcomes, Mortality, Complications and side effects, Risk factors, Comorbidity, Chronic kidney failure, Hemodialysis patients

---

Parathyroid hormone plus alendronate -- a combination that does not add up

Article Abstract:

People with osteoporosis should not be treated with parathyroid hormone and a bisphosphonate drug at the same time. Two studies published in 2003 show that this combination is actually worse than either treatment separately. For this reason, patients could begin taking parathyroid hormone for a year or two, then stop the hormone and start taking a bisphosphonate drug.

Care and treatment, Evaluation, Parathyroid hormone, Parathyroid hormones, Osteoporosis, Diphosphonates

---

Similar abstracts:

• Abstracts: Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia
• Abstracts: Effects of baking, pasta production, and extrusion cooking on formation of resistant starch. Effects of a diet with resistant starch in the rat
• Abstracts: Effect of deprenyl on the progression of disability in early Parkinson's disease. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.